Many U.S. seniors rely on cheaper prescription drugs from Canada, but new regulations and political pressure could restrict cross-border supplies, potentially driving up costs.
Donald Trump touted a breakthrough on lowering drug prices, but a closer look reveals pharmaceutical giants also benefited, raising questions about who truly gained from the policy shifts.